Your browser doesn't support javascript.
loading
Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo.
Kawakami, K; Kawakami, M; Husain, S R; Puri, R K.
Affiliation
  • Kawakami K; Laboratory of Molecular Tumor Biology, Division of Cellular and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, NIH Building 29, 29 Lincoln Drive, Bethesda, MD 20892-4555, USA.
Gene Ther ; 10(13): 1116-28, 2003 Jul.
Article in En | MEDLINE | ID: mdl-12808442
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Genetic Therapy / Immunotoxins / Receptors, Interleukin / Interleukin-13 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2003 Document type: Article Affiliation country: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Genetic Therapy / Immunotoxins / Receptors, Interleukin / Interleukin-13 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Gene Ther Journal subject: GENETICA MEDICA / TERAPEUTICA Year: 2003 Document type: Article Affiliation country: Estados Unidos